Publications:

Case Report: Durable Clinical Response to Third-Line Pyrotinib After Resistance to Trastuzumab in a Gastric Cancer Patient.

Frontiers In Oncology

Wu, Junyi J; Li, Lei L; Qin, Jun J; Yan, Zhengqing Z; Chen, Shiqing S; Jin, Tao T; Xu, Junming J

Publication Date: 2021

Variant appearance in text: JAK2: R971Gfs*27

PubMed Link: 35155188

Variant Present in the following documents:

• Main text
• fonc-11-780577.pdf

View BVdb publication page